Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for PU 1
Most Correlated Studies
- Double negative T cells overexpressing PU.1-ETS domain or PU.1-ETS-EN1 fusion proteins
- Myeloid progenitor PU.1 null cell line differentiation via a tamoxifen-induced ER-PU.1 transgene
- Hematopoietic stem cell proliferation in PU.1 knockin mice
- Bone marrow FDCP-mix cells depleted of Gata2 or Pu.1
- Bone marrow FDCP-mix cells conditionally overexpressing Gata1 or Pu.1
Most Relevant Literature
- Combined Approach to Leukemic Differentiation Using Transcription Factor PU.1-Enhancing Agents.
- Blood stem cell PU.1 upregulation is a consequence of differentiation without fast autoregulation.
- Intracellular Salmonella Paratyphi A is motile and differs in the expression of flagella-chemotaxis,…
- Transcription factor PU.1 and immune cell differentiation (Review).
- PU.1-Dependent Enhancer Inhibition Separates Tet2-Deficient Hematopoiesis from Malignant Transformat…
Most Relevant Clinical Trials
- FoxO3a and PU.1 in Acute Lymphoblastic Leukemia
- PET Imaging of Subjects Using 124I-PU-AD
- A Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of PU-AD in H…
- Evaluation of Ruxolitinib in Combination With PU-H71 for Treatment of Myelofibrosis
- To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Demen…
